Karuna Therapeutics (NASDAQ:KRTX) reported quarterly losses of $(2.38) per share. This is a 38.37 percent decrease over losses of $(1.72) per share from the same period last year.
Here’s How Much $1000 Invested In Westinghouse Air Brake 15 Years Ago Would Be Worth Today
Westinghouse Air Brake (NYSE:WAB) has outperformed the market over the past 15 years by 5.69% on an annualized…
